BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18332182)

  • 21. Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors.
    O'Callaghan CA
    Microbes Infect; 2000 Apr; 2(4):371-80. PubMed ID: 10817639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
    King A; Allan DS; Bowen M; Powis SJ; Joseph S; Verma S; Hiby SE; McMichael AJ; Loke YW; Braud VM
    Eur J Immunol; 2000 Jun; 30(6):1623-31. PubMed ID: 10898498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer.
    Llano M; Lee N; Navarro F; García P; Albar JP; Geraghty DE; López-Botet M
    Eur J Immunol; 1998 Sep; 28(9):2854-63. PubMed ID: 9754572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NK cell CD94/NKG2A inhibitory receptors are internalized and recycle independently of inhibitory signaling processes.
    Borrego F; Kabat J; Sanni TB; Coligan JE
    J Immunol; 2002 Dec; 169(11):6102-11. PubMed ID: 12444112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.
    Seo J; Park JS; Nam JH; Bang D; Sohn S; Lee ES; Park KS
    Tissue Antigens; 2007 Oct; 70(4):307-13. PubMed ID: 17767552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
    Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex.
    Pende D; Sivori S; Accame L; Pareti L; Falco M; Geraghty D; Le Bouteiller P; Moretta L; Moretta A
    Eur J Immunol; 1997 Aug; 27(8):1875-80. PubMed ID: 9295021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.
    Sala FG; Del Moral PM; Pizzato N; Legrand-Abravanel F; Le Bouteiller P; Lenfant F
    Immunogenetics; 2004 Dec; 56(9):617-24. PubMed ID: 15578261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.
    Boyington JC; Riaz AN; Patamawenu A; Coligan JE; Brooks AG; Sun PD
    Immunity; 1999 Jan; 10(1):75-82. PubMed ID: 10023772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.
    Malmberg KJ; Levitsky V; Norell H; de Matos CT; Carlsten M; Schedvins K; Rabbani H; Moretta A; Söderström K; Levitskaya J; Kiessling R
    J Clin Invest; 2002 Nov; 110(10):1515-23. PubMed ID: 12438449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA class I signal peptide polymorphism determines the level of CD94/NKG2-HLA-E-mediated regulation of effector cell responses.
    Lin Z; Bashirova AA; Viard M; Garner L; Quastel M; Beiersdorfer M; Kasprzak WK; Akdag M; Yuki Y; Ojeda P; Das S; Andresson T; Naranbhai V; Horowitz A; McMichael AJ; Hoelzemer A; Gillespie GM; Garcia-Beltran WF; Carrington M
    Nat Immunol; 2023 Jul; 24(7):1087-1097. PubMed ID: 37264229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
    Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in the ligand binding domains of the CD94/NKG2 family of receptors in the squirrel monkey.
    LaBonte ML; Russo J; Freitas S; Keighley D
    Immunogenetics; 2007 Oct; 59(10):799-811. PubMed ID: 17896104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors.
    Della Chiesa M; Vitale M; Carlomagno S; Ferlazzo G; Moretta L; Moretta A
    Eur J Immunol; 2003 Jun; 33(6):1657-66. PubMed ID: 12778484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CD94/NKG2 C-type lectin receptor complex: involvement in NK cell-mediated recognition of HLA class I molecules.
    López-Botet M; Carretero M; Pérez-Villar J; Bellón T; Llano M; Navarro F
    Immunol Res; 1997; 16(2):175-85. PubMed ID: 9212363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?
    Graham CM; Christensen JR; Thomas DB
    Immunology; 2007 Jun; 121(2):238-47. PubMed ID: 17462078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural basis of MHC class I recognition by natural killer cell receptors.
    Sawicki MW; Dimasi N; Natarajan K; Wang J; Margulies DH; Mariuzza RA
    Immunol Rev; 2001 Jun; 181():52-65. PubMed ID: 11513152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.